跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,591 条关于
“Empery Asset Management”
全部
9,591
临床试验
0
药物
0
机构
287
资讯
9,304
上个月
Lantern Pharma Spins Out Open-Medicine AI to Commercialize Its Multi-Agent AI Co-Scientist Platform
去年
X4 Pharmaceuticals Secures $85 Million Private Placement to Advance Mavorixafor Development
去年
Acelyrin's Izokibep Advances in Phase 3 Trials Amidst Analyst Revisions and Institutional Investment
去年
Norstella Launches NorstellaLinQ, an Integrated Data Asset for Biopharma
10个月前
Apimeds Pharmaceuticals Merges with AI-Driven Digital Asset Company MindWave in $100M Deal
去年
WuXi Companies Consider Asset Sales Amid US BIOSECURE Act Pressure
去年
Sareum Holdings Raises £2.4 Million to Advance TYK2/JAK1 Inhibitor SDC-1801
去年
Siren Biotechnology's SRN-101 Receives FDA Designations for High-Grade Gliomas
去年
Pharmaceutical Asset Purchase Deals Show Sustained Growth Since 2019, Report Reveals
10个月前
Adaptimmune Undergoes Major Leadership Restructuring Following Nasdaq Delisting and Asset Divestiture
第 1 页,共 931 页
上一页
下一页